Lysogene Pushes Forward With Sanfilippo Syndrome Study, Establishes Footprint in U.S. Post author:Sam Post published:October 24, 2017 Post category:BioPharma Finding a treatment for Sanfilippo Syndrome is a personal matter for the Lysogene team. Source: BioSpace You Might Also Like Akers Biosciences Reports Preliminary Unaudited Earnings Highlights For Fiscal Year 2016 March 30, 2017 Vertex Quietly Terminates a Small Phase II CF Trial September 11, 2017 AstraZeneca PLC Offloads Heart Drugs to Recordati in $300 Million Deal to Pump Up R&D May 21, 2017
Akers Biosciences Reports Preliminary Unaudited Earnings Highlights For Fiscal Year 2016 March 30, 2017
